First Republic Investment Management Inc. decreased its position in shares of HealthEquity, Inc. (NASDAQ:HQY – Get Rating) by 38.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,892 shares of the company’s stock after selling 11,012 shares during the period. First Republic Investment Management Inc.’s holdings in HealthEquity were worth $792,000 at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. IndexIQ Advisors LLC acquired a new stake in HealthEquity in the 4th quarter valued at about $27,000. Exchange Traded Concepts LLC raised its position in HealthEquity by 50.0% in the 4th quarter. Exchange Traded Concepts LLC now owns 990 shares of the company’s stock valued at $44,000 after purchasing an additional 330 shares in the last quarter. Econ Financial Services Corp acquired a new stake in HealthEquity in the 4th quarter valued at about $88,000. Dark Forest Capital Management LP acquired a new stake in shares of HealthEquity during the 3rd quarter worth about $95,000. Finally, Nisa Investment Advisors LLC raised its position in shares of HealthEquity by 10.9% during the 4th quarter. Nisa Investment Advisors LLC now owns 3,265 shares of the company’s stock worth $174,000 after acquiring an additional 320 shares in the last quarter. 97.44% of the stock is currently owned by institutional investors.
HQY opened at $57.68 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.29 and a quick ratio of 2.29. The business has a 50 day simple moving average of $62.51 and a 200-day simple moving average of $56.78. The stock has a market capitalization of $4.83 billion, a P/E ratio of -108.83, a P/E/G ratio of 4.78 and a beta of 1.08. HealthEquity, Inc. has a 12 month low of $36.81 and a 12 month high of $84.78.
Several equities research analysts have recently weighed in on HQY shares. TheStreet raised HealthEquity from a “d+” rating to a “c-” rating in a research report on Wednesday, April 6th. StockNews.com lowered HealthEquity from a “hold” rating to a “sell” rating in a research report on Sunday, March 27th. Zacks Investment Research upgraded HealthEquity from a “strong sell” rating to a “buy” rating and set a $58.00 price target on the stock in a research note on Tuesday, February 8th. Deutsche Bank Aktiengesellschaft raised their price target on HealthEquity from $62.00 to $66.00 and gave the stock a “buy” rating in a research note on Thursday, March 24th. Finally, Wells Fargo & Company began coverage on HealthEquity in a research note on Monday, April 11th. They set an “overweight” rating and a $95.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, HealthEquity presently has a consensus rating of “Buy” and a consensus price target of $77.33.
HealthEquity Company Profile (Get Rating)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
- Get a free copy of the StockNews.com research report on HealthEquity (HQY)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.